🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a double-blind study evaluating Desvenlafaxine Succinate Sustained-...
Status
Completed
Location
Children's Hospital of Alabama Laboratory
Start Date
2011-08
Trial ID
NCT01371734
Treatments Being Tested
This is a 6-month, open-label, flexible-dose study evaluating Desvenlafaxin...
Status
Completed
Location
The University Of Alabama At Birmingham, Office Of Psychiatric Research
Start Date
2012-02-02
Trial ID
NCT01371708
Treatments Being Tested
The main purpose of this study is to evaluate the effect of desvenlafaxine ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-06
Trial ID
NCT00952653
Treatments Being Tested
The purpose of this study is to evaluate the effects of multiple doses of D...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00329147
Treatments Being Tested
The primary objective is to evaluate the long-term safety of desvenlafaxine...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00424892
Treatments Being Tested
The primary purpose of this study is to test the safety and tolerability of...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-02
Trial ID
NCT00619619
Treatments Being Tested
To determine the bioequivalence of 2 tablets of 25 mg sustained release (SR...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-09
Trial ID
NCT01190514
The purpose of this study is to evaluate the efficacy and safety of 100 mg ...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00369434
Treatments Being Tested
This study will assess the safety, tolerability and efficacy of desvenlafax...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00445679
Treatments Being Tested
This is a Double-blind Study Evaluating Desvenlafaxine Succinate (DVS SR) S...
Status
Completed
Location
Harmonex Neuroscience Research, Inc.
Start Date
2011-11-17
Trial ID
NCT01372150
Treatments Being Tested